[Thermochemotherapy for malignant melanoma--combined therapy of anti-tumor agents and hyperthermia in mice].
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage*; D006979:Hyperthermia, Induced; D008297:Male; D008545:Melanoma / Q000628:therapy*; D051379:Mice; D008810:Mice, Inbred C57BL; D015376:Nimustine; D009607:Nitrosourea Compounds / Q000008:administration & dosage*; D012878:Skin Neoplasms / Q000628:therapy*; D014226:Triazenes / Q000008:administration & dosage*
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D014226:Triazenes; D015376:Nimustine; C022868:3-(3,3-dimethyl-1-triazeno)pyrazole-4-carboxamide; D004317:Doxorubicin